Drugs / [18F]-FMH3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01268020 | Dec 2010 → Oct 2012 | Alzheimer disease | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]-FMH3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01268020 ↗ |